Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double‐blinded, placebo‐controlled, phase II clinical trial

Overview of attention for article published in Cancer Communications, December 2017

Altmetric Badge

Mentioned by

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 52 Mendeley

Summary Wikipedia Dimensions citations

So far, Altmetric has seen 1 Wikipedia article.

Famitinib

Cited by user Buidhe on 29 Nov 2023

Famitinib is a tyrosine kinase receptor inhibitor developed by Jiangsu Hengrui for a variety of cancers.

This page shows the most recent Wikipedia articles that mention this research output.

Click here to find out how to access more activity.